From Breakthrough to Boxed Warning: Trikafta’s Liver Failure Risks and Implications for CF Care Decisions

Trikafta Black Box Warning

Trikafta is a prescription medication used to treat cystic fibrosis (CF), a genetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, leading to impaired chloride transport, thick mucus accumulation, and progressive damage to the lungs, pancreas, and other organs. Trikafta combines elexacaftor and tezacaftor (correctors that improve CFTR protein folding […]